ACVR1C
Basic information
Region (hg38): 2:157526767-157628864
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (35 variants)
- not_provided (10 variants)
- ACVR1C-related_disorder (9 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACVR1C gene is commonly pathogenic or not. These statistics are base on transcript: NM_000145259.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 35 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 35 | 3 | 7 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACVR1C | protein_coding | protein_coding | ENST00000243349 | 9 | 102239 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000852 | 0.999 | 125710 | 0 | 38 | 125748 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.50 | 198 | 267 | 0.742 | 0.0000134 | 3174 |
Missense in Polyphen | 70 | 133.44 | 0.5246 | 1627 | ||
Synonymous | 0.0706 | 96 | 96.9 | 0.991 | 0.00000516 | 962 |
Loss of Function | 3.00 | 10 | 26.7 | 0.374 | 0.00000156 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000905 | 0.0000905 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000255 | 0.000246 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000717 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine protein kinase which forms a receptor complex on ligand binding. The receptor complex consisting of 2 type II and 2 type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators, SMAD2 and SMAD3. Receptor for activin AB, activin B and NODAL. Plays a role in cell differentiation, growth arrest and apoptosis. {ECO:0000269|PubMed:12063393, ECO:0000269|PubMed:15531507}.;
- Pathway
- TGF-beta signaling pathway - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);TGF-Core;Developmental Biology;Regulation of signaling by NODAL;Signal Transduction;Signaling by Activin;Signaling by NODAL;Signaling by TGF-beta family members
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.0761
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.01
Haploinsufficiency Scores
- pHI
- 0.759
- hipred
- Y
- hipred_score
- 0.635
- ghis
- 0.464
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.765
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acvr1c
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- response to dietary excess;protein phosphorylation;transforming growth factor beta receptor signaling pathway;pattern specification process;response to glucose;lipid storage;cell differentiation;apoptotic nuclear changes;response to insulin;activin receptor signaling pathway;nodal signaling pathway;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of insulin secretion;negative regulation of trophoblast cell migration;negative regulation of chorionic trophoblast cell proliferation
- Cellular component
- plasma membrane;integral component of plasma membrane;receptor complex;activin receptor complex
- Molecular function
- protein serine/threonine kinase activity;transforming growth factor beta-activated receptor activity;transforming growth factor beta receptor activity, type I;ATP binding;activin receptor activity, type I;growth factor binding;nodal binding;SMAD binding;metal ion binding;activin binding